Johns Hopkins Medicine

The New Cholesterol Guideline: What to Know

For the first time since 2018, a clinical guideline from the American College of Cardiology and the American Heart ...
Science Daily

Controlling lipid levels with fewer side effects possible with new drug

Researchers have developed a new compound, ZTA-261, that binds to thyroid hormone receptor beta (THR ). THR plays an important role in the regulation of lipid metabolism, which affects lipid levels in ...
The Cardiology Advisor

ACC/AHA Release Updated 2026 Dyslipidemia Management Guidelines

New ACC/AHA guidelines provide updated recommendations for dyslipidemia management, focusing on atherogenic lipoproteins and ...
Medscape

Screening for Lipid Disorders in Children: U.S. Preventive Services Task Force Recommendation Statement

This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in children. This recommendation statement was first published in ...

Abdominal fat bigger risk than overall obesity in India: Dr Jitendra Singh

He also cautioned against extreme or unscientific fitness practices and underlined the value of balanced living, adequate sleep, and scientifically guided preventive care. The textbook, edited by H.K.
Odisha Diary

Abdominal or central obesity is a greater risk factor compared to overall obesity, particularly in the Indian context where even lean and thin-looking individuals often carry ...

Union Minister of State (Independent Charge) for Science & Technology, Earth Sciences, and MoS PMO, Personnel, Public Grievances & Pensions, Department of Atomic Energy and Department of ...
EurekAlert!

Controlling lipid levels with less side effects possible with new drug

Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders. They have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone ...